Etsushi Kuroda Selected Research

Etsushi Kuroda Research Topics

Disease

16	Inflammation (Inflammations) 12/2023 - 01/2011
13	Neoplasms (Cancer) 01/2024 - 09/2002
7	Human Influenza (Influenza) 01/2022 - 01/2013
7	Infections 12/2021 - 06/2017
6	Pneumonia (Pneumonitis) 12/2021 - 04/2013
5	Bites and Stings (Sting) 01/2024 - 04/2015
5	Hypersensitivity (Allergy) 01/2022 - 07/2008
4	Glioma (Gliomas) 02/2008 - 09/2002
3	Communicable Diseases (Infectious Diseases) 11/2022 - 01/2018
3	Lung Injury 12/2021 - 05/2007
2	Lung Neoplasms (Lung Cancer) 01/2024 - 07/2022
2	Virus Diseases (Viral Diseases) 12/2022 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 08/2016
2	Atopic Dermatitis (Atopic Eczema) 09/2021 - 07/2013
2	Asthma (Bronchial Asthma) 01/2019 - 04/2013
2	Contact Dermatitis (Eczema, Contact) 05/2014 - 07/2013
1	Disease Progression 01/2024
1	Cognitive Dysfunction 12/2023
1	Encephalitis (Encephalitis, Rasmussen) 12/2023
1	Necrosis 01/2022
1	Mycoplasma Pneumonia 12/2021
1	Nematode Infections 01/2020
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2020
1	Retinoblastoma (Glioblastoma, Retinal) 01/2020
1	Tuberculosis (Tuberculoses) 01/2018
1	Paramyxoviridae Infections (Parainfluenza) 01/2018
1	Malaria 06/2017

Drug/Important Bio-Agent (IBA)

11	VaccinesIBA 01/2022 - 01/2013
7	CytokinesIBA 12/2023 - 01/2013
7	AntigensIBA 12/2022 - 03/2015
5	Interleukin-12 (IL 12)IBA 01/2022 - 02/2003
5	Vaccine AdjuvantsIBA 01/2022 - 04/2015
5	Interleukin-33IBA 09/2021 - 01/2019
4	InterferonsIBA 01/2024 - 02/2005
4	ChemokinesIBA 01/2015 - 07/2008
3	CPG-oligonucleotideIBA 07/2022 - 04/2015
3	OvalbuminIBA 01/2022 - 09/2012
3	titanium dioxide (Titania)FDA Link 01/2022 - 01/2011
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2020
3	Dinoprostone (PGE2)FDA Link 01/2020 - 04/2006
2	vadimezanIBA 01/2024 - 01/2013
2	OligodeoxyribonucleotidesIBA 07/2022 - 04/2015
2	Cancer VaccinesIBA 01/2022 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2014
2	PapainIBA 01/2020 - 04/2006
2	AluminumIBA 01/2020 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2019
2	SaltsIBA 01/2020 - 01/2020
2	Immunoglobulin E (IgE)IBA 12/2019 - 01/2019
2	InterleukinsIBA 12/2019 - 04/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2017
2	Antiviral Agents (Antivirals)IBA 01/2019 - 03/2009
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2019 - 04/2015
2	Interferon Type IIBA 08/2016 - 01/2013
2	CyclodextrinsIBA 01/2016 - 03/2015
2	LigandsIBA 01/2016 - 04/2015
2	nickel monoxide (nickel oxide)IBA 10/2014 - 01/2011
2	HaptensIBA 05/2014 - 07/2008
2	EnzymesIBA 02/2008 - 04/2006
2	Prostaglandins EIBA 02/2008 - 04/2006
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2008 - 04/2006
2	ProstaglandinsIBA 02/2008 - 04/2006
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2003 - 09/2002
2	ThymidineIBA 02/2003 - 09/2002
1	Therapeutic UsesIBA 01/2024
1	P-selectin ligand proteinIBA 12/2023
1	LipopolysaccharidesIBA 12/2023
1	Subunit VaccinesIBA 11/2022
1	GuanineIBA 07/2022
1	Phosphates (Orthophosphate)IBA 07/2022
1	CytosineIBA 07/2022
1	Single-Stranded DNA (DNA, Single Stranded)IBA 07/2022
1	Interleukin-12 Subunit p40IBA 01/2022
1	Thymic Stromal LymphopoietinIBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2020
1	InflammasomesIBA 01/2020
1	amlexanox (Aphthasol)FDA Link 01/2019
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2018
1	Pattern Recognition ReceptorsIBA 01/2018
1	Nucleic AcidsIBA 01/2018
1	Antimalarials (Antimalarial Agents)IBA 06/2017
1	Hemoglobins (Hemoglobin)IBA 06/2017
1	hemozoinIBA 06/2017
1	AllergensIBA 01/2017
1	Neoplasm Antigens (Tumor Antigens)IBA 08/2016
1	K3-SPGIBA 08/2016
1	incomplete Freund's adjuvantIBA 01/2016
1	C-Type Lectins (C-Type Lectin)IBA 01/2016
1	aluminum sulfate (alum)IBA 01/2016
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2016
1	Viral AntigensIBA 01/2016

Therapy/Procedure

3	Immunotherapy 07/2022 - 01/2016
2	Therapeutics 12/2021 - 06/2017
1	Subcutaneous Infusions 12/2023
1	Intranasal Administration 01/2020
1	Immunomodulation 12/2019
1	Oral Administration 01/2019
1	Intravenous Injections 08/2016